000 01621 a2200421 4500
005 20250514052659.0
264 0 _c20030107
008 200301s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm020921f
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrown, Gavin D
245 0 0 _aAntitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cDec 2002
300 _a5448-57 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aBrain Diseases
_xdiagnostic imaging
650 0 4 _aCarbon Radioisotopes
650 0 4 _aCyclization
650 0 4 _aDacarbazine
_xanalogs & derivatives
650 0 4 _aGas Chromatography-Mass Spectrometry
650 0 4 _aHumans
650 0 4 _aIsotope Labeling
650 0 4 _aMagnetic Resonance Spectroscopy
650 0 4 _aParietal Lobe
_xdiagnostic imaging
650 0 4 _aProdrugs
_xchemical synthesis
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTemozolomide
650 0 4 _aTomography, Emission-Computed
700 1 _aLuthra, Sajinder K
700 1 _aBrock, Cathryn S
700 1 _aStevens, Malcolm F G
700 1 _aPrice, Patricia M
700 1 _aBrady, Frank
773 0 _tJournal of medicinal chemistry
_gvol. 45
_gno. 25
_gp. 5448-57
856 4 0 _uhttps://doi.org/10.1021/jm020921f
_zAvailable from publisher's website
999 _c12264858
_d12264858